| Multiple Sclerosis (MS) Agents - PA, NF |
Aubagio (teriflunomide), Avonex (interferon beta-1a), Bafiertam (monomethyl fumarate), Betaseron (interferon beta-1b), Briumvi (ublituximab-xiiy), Copaxone (glatiramer acetate), Extavia (interferon beta-1b), Glatopa (glatiramer acetate), Kesimpta (ofatumumab), Mayzent (siponimod), Plegridy (peginterferon beta-1a), Ponvory (ponesimod), Rebif (interferon beta-1a), Vumerity (diroximel fumarate), Lemtrada (alemtuzumab), Mavenclad (cladribine), Ocrevus (ocrelizumab), Ocrevus Zunovo (ocrelizumab), Tascenso ODT (fingolimod) |
| Myalept (metreleptin for injection) |
Myalept (metreleptin for injection) |
| Myobloc (rimabotulinumtoxin B) |
Myobloc (rimabotulinumtoxin B) |
| Myqorzo (aficamten) |
Myqorzo (aficamten) |
| Naglazyme (galsulfase injection) |
Naglazyme (galsulfase injection) |
| Namzaric (memantine/donepezil) |
Namzaric (memantine and donepezil hydrochloride) |
| Nasal Steroids |
Xhance (fluticasone propionate) |
| Nascobal (cyanocobalamin) Spray- Non Formulary |
Nascobal (cyanocobalamin) Spray |
| Natalizumab Products |
Tysabri (natalizumab), Tyruko (natalizumab-sztn) |
| Nemluvio (nemolizumab-ilto) |
Nemluvio (nemolizumab-ilto) |
| Nerlynx (neratinib) |
Nerlynx (neratinib) |
| Neurologic Agents |
Gralise (gabapentin), Lyrica CR (pregabalin extended-release), Savella (milnacipran), Tonmya (cyclobenzaprine) |
| New Drug to Market Program - PA |
New drug to market |
| New Drug to Market Program - PA |
New drug to market |
| Nexavar (sorafenib) |
Nexavar (sorafenib) |
| Nexletol (bempedoic acid) and Nexlizet (bempedoic acid-ezetimibe) |
Nexletol (bempedoic acid), Nexlizet (bempedoic acid-ezetimibe) |
| Nexviazyme (avalglucosidase alfa-ngpt) |
Nexviazyme (avalglucosidase alfa-ngpt) |
| Niktimvo (axatilimab-csfr)- PA, NF |
Niktimvo (axatilimab-csfr) |
| Nilotinib Products- PA, NF |
Danziten (nilotinib tartrate), Nilotinib (nilotinib D-tartrate), Tasigna (nilotinib hydrochloride) |
| Ninlaro (ixazomib citrate) |
Ninlaro (ixazomib citrate) |
HEALTHY LIVING